GDF15 and Cirrhosis: Our study now expands the evidence on the prognostic role of GDF‐15 to patients with cirrhosis by demonstrating a significant link between elevated GDF‐15 and the risk of hepatic decompensation—independently from hepatic dysfunction, portal hypertension severity, as assessed by gold‐standard HVPG measurements, and systemic inflammation.